ArticleAnti-cancer drugs2022

Tumor-mutation burden as a marker for immunotherapy of pancreatic cancer: the case report and literature review.

Peng-Fei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.